Dollars for Docs: Talk With Your Doctor
https://projects.propublica.org/docdollars/
You can print this page and show it to your doctor.
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
ProPublica's Dollars for Docs database lets you search for payments to U.S.-based doctors made by pharmaceutical and medical device companies between August 2013 and December 2018. The disclosure of these payments is required under the Physician Payments Sunshine Act, a provision of the 2010 Affordable Care Act.
About This Information
- The information that appears here comes directly from the federal government. Companies must attest to its accuracy, and doctors have the ability to contest information they believe is in error.
- This site includes payments for such activities as speaking, consulting, meals, travel and royalties. It does not include payments for clinical research.
- It is legal for companies to make payments to doctors as long as the payments are not a kickback or inducement to use their products.
- Some doctors say collaborative relationships, particularly those involving research, are necessary to develop new treatments and cures. But many ethicists have raised questions about the payments, and studies show that they may influence doctors' prescribing decisions.
- Only you can decide if this matters to you and if so, whether you want to talk with your doctor about it. If you plan to talk with your doctor (or if you already have), please help us by filling out this short survey: propub.li/participate-d4d
Preparing for Your Conversation
If you decide you'd like to talk to your doctor about this, please keep in mind:
- Many health care professionals in our database have similar names, so you should start by asking your doctor if the person mentioned in this payment record is really him/her.
- Your doctor may not know he or she is listed as receiving payments, especially if the payments are small. You can direct your doctor to this site (the URL will be printed at the top of the payment record) or directly to the government's site here: https://openpaymentsdata.cms.gov/physician/309168
- Some doctors are happy to discuss this information with you. Others might not be. The best approach is to ask questions and to not be accusatory.
Questions You Might Want to Ask
- Is this you?
- What type of work do you do with these companies?
- Have you prescribed me any drugs that are manufactured by companies you've taken payments from?
- Are there non-drug alternatives that I may want to consider first?
- Are there less expensive generic alternatives to the drugs you have prescribed?
- What devices have you used in my care that are manufactured by companies you've taken payments from?
Dollars for Docs: Talk With Your Doctor
https://projects.propublica.org/docdollars/doctors/pid/309168
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
NATARAJAN RAVENDHRAN
Listed Specialty: Gastroenterology
700 GEIPE RD, STE 230, CATONSVILLE, MD, 21228-4147
2018 Payments: At a Glance
253
payments
$100,438
payment total
21
companies paid this doctor
Types of Payments
| Category | Payments | Payment Value |
|---|---|---|
Promotional Speaking/Other |
24 | $61,360 |
Consulting |
5 | $18,315 |
Travel and Lodging |
44 | $15,005 |
Food and Beverage |
177 | $5,744 |
Education |
3 | $15 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
| Product Name | Product Type | Payments† |
|---|---|---|
EPCLUSA |
drug |
$29,289 |
MAVYRET |
drug |
$21,058 |
VEMLIDY |
drug |
$20,047 |
Payments with no listed product |
N/A |
$14,508 |
NEXAVAR |
drug |
$6,087 |
STIVARGA |
drug |
$6,087 |
ZEPATIER |
drug |
$3,837 |
XIFAXAN |
drug |
$3,056 |
ALINIA |
drug |
$1,632 |
LINZESS |
drug |
$135 |
AMITIZA |
drug |
$121 |
STELARA |
drug |
$115 |
SIMPONI |
drug |
$98 |
ENTYVIO |
drug |
$91 |
VIBERZI |
drug |
$86 |
CREON |
drug |
$83 |
TRULANCE |
drug |
$67 |
OCALIVA |
drug |
$44 |
ZENPEP |
drug |
$40 |
RELISTOR |
drug |
$38 |
| † May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. | ||
For ease of printing, only the 20 drugs and devices with the highest payments are displayed. For a complete list, please visit: https://projects.propublica.org/docdollars/doctors/pid/309168
Payment Details
| When | How Much | Related To | What For | From | Third Party Payee |
|---|---|---|---|---|---|
| May 3, 2018 | $7,190 | No Listed Product | Consulting | GILEAD SCIENCES INC | |
| Apr 28, 2018 | $5,000 | NEXAVAR STIVARGA | Consulting | BAYER HEALTHCARE PHARMACEUTICALS INC. | |
| May 1, 2018 | $4,375 | MAVYRET | Promotional Speaking/Other | ABBVIE, INC. | |
| Aug 21, 2018 | $4,000 | EPCLUSA | Consulting | GILEAD SCIENCES INC | |
| Nov 1, 2018 | $3,500 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Sep 19, 2018 | $3,500 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Apr 2, 2018 | $3,185 | ZEPATIER | Promotional Speaking/Other | MERCK SHARP & DOHME CORPORATION | |
| Jan 30, 2018 | $3,125 | MAVYRET | Promotional Speaking/Other | ABBVIE, INC. | |
| Aug 13, 2018 | $3,125 | MAVYRET | Promotional Speaking/Other | ABBVIE, INC. | |
| Oct 4, 2018 | $3,125 | MAVYRET | Promotional Speaking/Other | ABBVIE, INC. | |
| Dec 10, 2018 | $3,125 | MAVYRET | Promotional Speaking/Other | ABBVIE, INC. | |
| Sep 15, 2018 | $3,000 | VEMLIDY | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Jun 2, 2018 | $3,000 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Nov 21, 2018 | $3,000 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Jun 7, 2018 | $2,800 | XIFAXAN | Travel and Lodging | SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC | |
| Apr 4, 2018 | $2,500 | EPCLUSA | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Jun 14, 2018 | $2,500 | VEMLIDY | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Oct 1, 2018 | $2,500 | VEMLIDY | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Feb 7, 2018 | $2,500 | No Listed Product | Promotional Speaking/Other | GILEAD SCIENCES INC | |
| Nov 2, 2018 | $2,500 | VEMLIDY | Promotional Speaking/Other | GILEAD SCIENCES INC |
For ease of printing, 20 payments are displayed, the largest appearing on top. For a full list of payments, please visit: https://projects.propublica.org/docdollars/doctors/pid/309168
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.